Crossmark

Improvement in renal function after switching from entecavir to tenofovir alafenamide in chronic hepatitis B patients with low estimated glomerular filtration rates

Crossref DOI link: https://doi.org/10.1016/j.aohep.2025.101925

Published Print: 2025-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Wang, Liang

Ma, Shipeng

Malhi, Lajpat Rai

Wu, Xiaoping

Liu, Liping

Wan, Xin

Zhang, Yuliang

Li, Xiaopeng

Ge, Shanfei
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81660109)

Chinese Foundation for Hepatitis Prevention and Control (MX202418)
License Information

Text and Data Mining valid from 2025-07-01

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-05-12
More Information

This article is maintained by: Elsevier

Article Title: Improvement in renal function after switching from entecavir to tenofovir alafenamide in chronic hepatitis B patients with low estimated glomerular filtration rates

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2025.101925

Content Type: article

Copyright: © 2025 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below